» Articles » PMID: 17394684

Survival and Relapse Rate of Tuberculosis Patients Who Successfully Completed Treatment in Vietnam

Overview
Specialty Pulmonary Medicine
Date 2007 Mar 31
PMID 17394684
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Setting: Reported tuberculosis (TB) cure rates are high in Vietnam with the 8-month short-course chemotherapy regimen. However, long-term treatment outcomes are unknown.

Objective: To assess survival and relapse rates among patients successfully treated for new smear-positive pulmonary tuberculosis (PTB).

Methods: A cohort of patients treated in 32 randomly selected districts in northern Vietnam were followed up 12-24 months after reported cure or treatment success for survival and bacteriologically confirmed relapse. Measurements included sputum smear examination, culture and interview for recent treatment history.

Results: Of 304 patients included in the study, no information was available for 31 (10%) and 19 (6%) had died. Bacteriology results were available for 244 (80%). The median interval between treatment completion and follow-up was 19 months. Relapse was recorded in 21/244 (8.6%, 95%CI 5.4-13), including 9 (4%) with positive sputum smears, 3 (1%) with negative smears but positive culture and 9 (4%) who had started TB retreatment. Four of 12 culture-positive relapse cases (33%) had multidrug-resistant strains. If the definition of relapse was extended to include death, reportedly due to TB, the relapse proportion was 26/263 (9.9%, 95%CI 6.6-14).

Conclusion: A substantial proportion of patients (15%) had died or relapsed after being successfully treated for TB in northern Vietnam.

Citing Articles

Multidrug-resistant tuberculosis.

Dheda K, Mirzayev F, Cirillo D, Udwadia Z, Dooley K, Chang K Nat Rev Dis Primers. 2024; 10(1):22.

PMID: 38523140 DOI: 10.1038/s41572-024-00504-2.


Demographic and Clinical Determinants of Tuberculosis and TB Recurrence: A Double-Edged Retrospective Study from Pakistan.

Mujtaba M, Richardson M, Shahzad H, Javed M, Raja G, Shaiq P J Trop Med. 2022; 2022:4408306.

PMID: 36478977 PMC: 9722313. DOI: 10.1155/2022/4408306.


Prospective 1-year follow-up study of all cured, new sputum smear positive tuberculosis patients under the Revised National Tuberculosis Control Program in Hyderabad, Telangana State, India.

Mathur N, Chatla C, Syed S, Patel Y, Pattnaik S, Mathai D Lung India. 2019; 36(6):519-524.

PMID: 31670300 PMC: 6852225. DOI: 10.4103/lungindia.lungindia_143_19.


Long-term outcome of smear-positive tuberculosis patients after initiation and completion of treatment: A ten-year retrospective cohort study.

Dangisso M, Markos Woldesemayat E, Datiko D, Lindtjorn B PLoS One. 2018; 13(3):e0193396.

PMID: 29529036 PMC: 5846790. DOI: 10.1371/journal.pone.0193396.


Impact of Multidrug Resistance on Tuberculosis Recurrence and Long-Term Outcome in China.

Sun Y, Harley D, Vally H, Sleigh A PLoS One. 2017; 12(1):e0168865.

PMID: 28118372 PMC: 5261560. DOI: 10.1371/journal.pone.0168865.